Muzastotug (ADG126) is a humanized monoclonal antibody targeting CTLA-4/CD152 that selectively inhibits CTLA-4-mediated regulatory T cells (Tregs) in the tumor microenvironment, demonstrating anti-tumor immunotherapy efficacy.
Purity:
95.00%
CAS Number:
[2750031-18-4]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted